VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 404 filers reported holding VALEANT PHARMACEUTICALS INTL in Q1 2016. The put-call ratio across all filers is 0.94 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $216,000 | -74.2% | 8,225 | 0.0% | 0.13% | -83.3% |
| Q4 2015 | $836,000 | +14.4% | 8,225 | +100.6% | 0.77% | +51.2% |
| Q3 2015 | $731,000 | -19.8% | 4,100 | 0.0% | 0.51% | -9.4% |
| Q2 2015 | $911,000 | +11.9% | 4,100 | 0.0% | 0.56% | +25.6% |
| Q1 2015 | $814,000 | +38.7% | 4,100 | 0.0% | 0.45% | +8.2% |
| Q4 2014 | $587,000 | +9.1% | 4,100 | 0.0% | 0.42% | +78.5% |
| Q3 2014 | $538,000 | +4.1% | 4,100 | 0.0% | 0.23% | 0.0% |
| Q2 2014 | $517,000 | – | 4,100 | – | 0.23% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Brave Warrior Advisors | 6,050,442 | $763,082,000 | 30.78% |
| LeVasseur Capital Partners LLC | 190,404 | $24,014,000 | 29.50% |
| FARLEY CAPITAL L.P. | 333,081 | $42,008,000 | 27.09% |
| Ruane, Cunniff & Goldfarb | 34,298,384 | $4,325,712,000 | 23.07% |
| ValueAct Holdings | 18,923,877 | $2,386,679,000 | 17.64% |
| Tesuji Partners | 1,368,040 | $172,537,000 | 17.22% |
| Brahman Capital Corp. | 3,902,877 | $492,231,000 | 13.63% |
| Arrow Capital Management, LLC | 197,500 | $24,909,000 | 13.60% |
| Hound Partners | 2,851,175 | $359,590,000 | 13.45% |
| Ratan Capital Management LP | 731,960 | $92,315,000 | 13.09% |